8HWT image
Entry Detail
PDB ID:
8HWT
EMDB ID:
Title:
SARS-CoV-2 Omicron BA.2 RBD complexed with BD-604 and S304 Fab
Biological Source:
PDB Version:
Deposition Date:
2023-01-02
Release Date:
2023-12-06
Method Details:
Experimental Method:
Resolution:
2.91 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Spike protein S2'
Chain IDs:A
Chain Length:223
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Description:S304 heavy chain
Chain IDs:D
Chain Length:231
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:S304 light chain
Chain IDs:E
Chain Length:216
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:BD-604 heavy chain
Chain IDs:B (auth: H)
Chain Length:229
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:BD-604 light chain
Chain IDs:C (auth: L)
Chain Length:215
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB.
Cell Rep Med 4 100991 100991 (2023)
PMID: 37019110 DOI: 10.1016/j.xcrm.2023.100991

Abstact

Emerging Omicron sub-variants are causing global concerns, and their immune evasion should be monitored continuously. We previously evaluated the escape of Omicron BA.1, BA.1.1, BA.2, and BA.3 from an atlas of 50 monoclonal antibodies (mAbs), covering seven epitope classes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD). Here, we update the atlas of totally 77 mAbs against emerging sub-variants including BQ.1.1 and XBB and find that BA.4/5, BQ.1.1, and XBB display further evasion. Besides, investigation into the correlation of binding and neutralization of mAbs reveals the important role of antigenic conformation in mAb functioning. Moreover, the complex structures of BA.2 RBD/BD-604/S304 and BA.4/5 RBD/BD-604/S304/S309 further elucidate the molecular mechanism of antibody evasion by these sub-variants. By focusing on the identified broadly potent mAbs, we find a general hotspot epitope on the RBD, which could guide the design of vaccines and calls for new broad-spectrum countermeasures against COVID-19.

Legend

Protein

Chemical

Disease

Primary Citation of related structures